Biblio

Nair P, Yamamoto T, Kulkarni V, Moye S, Navratilova E, Davis P, Largent T, Ma S-W, Yamamura HI, Vanderah T et al..  2009.  Novel bifunctional peptides as opioid agonists and NK-1 antagonists.. Adv Exp Med Biol. 611:537-8.

McCaffrey G, Willis CL, Staatz WD, Nametz N, Quigley CA, Hom S, Lochhead JJ, Davis TP.  2009.  Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress.. J Neurochem. 110(1):58-71.

Liu L, Wang J, Zhao L, Nilsen J, McClure K, Wong K, Brinton RDiaz.  2009.  Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2.. Endocrinology. 150(7):3186-96.

Junk DJ, Vrba L, Watts GS, Oshiro MM, Martinez JD, Futscher BW.  2008.  Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells.. Neoplasia. 10(5):450-61.

Watts GS, Futscher BW, Holtan N, Degeest K, Domann FE, Rose SL.  2008.  DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage.. BMC Med Genomics. 1:47.

Wang JMing, Liu L, Brinton RDiaz.  2008.  Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extracellularly regulated kinase pathway.. Endocrinology. 149(1):208-18.

Foy MR, Baudry M, Brinton RDiaz, Thompson RF.  2008.  Estrogen and hippocampal plasticity in rodent models.. J Alzheimers Dis. 15(4):589-603.

Brinton RDiaz.  2008.  Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease.. Adv Drug Deliv Rev. 60(13-14):1504-11.

Brinton RDiaz.  2008.  The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications.. Trends Neurosci. 31(10):529-37.

Tumati S, Milnes TLargent, Yamamura HI, Vanderah TW, Roeske WR, Varga EV.  2008.  Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia.. Eur J Pharmacol. 601(1-3):207-8.

Vanderah TW, Largent-Milnes T, Lai J, Porreca F, Houghten RA, Menzaghi F, Wisniewski K, Stalewski J, Sueiras-Diaz J, Galyean R et al..  2008.  Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.. Eur J Pharmacol. 583(1):62-72.

Largent-Milnes TM, Guo W, Wang H-Y, Burns LH, Vanderah TW.  2008.  Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.. J Pain. 9(8):700-13.

Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RDiaz, Nilsen J.  2008.  Progesterone and estrogen regulate oxidative metabolism in brain mitochondria.. Endocrinology. 149(6):3167-75.

Brinton RDiaz, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ et al..  2008.  Progesterone receptors: form and function in brain.. Front Neuroendocrinol. 29(2):313-39.

Wang JMing, Liu L, Irwin RW, Chen S, Brinton RDiaz.  2008.  Regenerative potential of allopregnanolone.. Brain Res Rev. 57(2):398-409.

Streicher JM, Wang Y.  2008.  The role of COX-2 in heart pathology.. Cardiovasc Hematol Agents Med Chem. 6(1):69-79.

Watts GS, Tran NL, Berens ME, Bhattacharyya AK, Nelson MA, Montgomery EA, Sampliner RE.  2007.  Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma.. Int J Cancer. 121(10):2132-9.

Goulet A-C, Watts G, Lord JL, Nelson MA.  2007.  Profiling of selenomethionine responsive genes in colon cancer by microarray analysis.. Cancer Biol Ther. 6(4):494-503.

Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE.  2006.  AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.. Oncogene. 25(39):5405-15.

Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW.  2006.  Epigenetic inactivation of the HOXA gene cluster in breast cancer.. Cancer Res. 66(22):10664-70.

Ignatenko NA, Yerushalmi HF, Watts GS, Futscher BW, Stringer DE, Marton LJ, Gerner EW.  2006.  Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161.. Technol Cancer Res Treat. 5(6):553-64.

D Sparks L, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C.  2005.  Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.. Arch Neurol. 62(5):753-7.

D Sparks L, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J et al..  2005.  Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.. Curr Alzheimer Res. 2(3):343-53.

Bethea CL, Streicher JM, Mirkes SJ, Sanchez RL, Reddy AP, Cameron JL.  2005.  Serotonin-related gene expression in female monkeys with individual sensitivity to stress.. Neuroscience. 132(1):151-66.

Sparks D.L., Lochhead J., Fisher A., Martin T..  2005.  Water Quality and Cholesterol-induced pathology: differential effects of the M-1 muscarinic receptor agaonist AF267b on accumulation of Alzheimer-like Amyloid B in rabbit brain. Recent Progress in Alzheimer's and Parkinson's Diseases. :197-203.